Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2011

Feb 28, 2011

30071_dirs_2011-02-28_76ee833a-ea5a-4f34-b3ab-86ec2da76477.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2011-02-24

Reporting Person: TAYLOR RONALD R (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-02-24 ResMed Common Stock M 36000 $23.875 Acquired 57255 Direct
2011-02-24 ResMed Common Stock S 36000 $31.152 Disposed 21255 Direct
2011-02-24 ResMed Common Stock M 12000 $23.095 Acquired 33255 Direct
2011-02-24 ResMed Common Stock S 12000 $31.153 Disposed 21255 Direct
2011-02-24 ResMed Common Stock M 36000 $21.025 Acquired 57255 Direct
2011-02-24 ResMed Common Stock S 36000 $31.152 Disposed 21255 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-02-24 ResMed Common Stock Options $23.875 M 36000 Disposed 2016-07-07 ResMed Common Stock (36000) Direct
2011-02-24 ResMed Common Stock Options $23.095 M 12000 Disposed 2013-11-10 ResMed Common Stock (12000) Direct
2011-02-24 ResMed Common Stock Options $21.025 M 36000 Disposed 2014-11-07 ResMed Common Stock (36000) Direct

Footnotes

F1: Represents first day options became exercisable.

F2: This transaction was executed in multiple trades at prices ranging from $31.072 to $31.232. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.